William Hoffman, Director at Inari Medical, Inc. (NARI), sold 40,000 shares at $65.38 ($2.6M) on 2023-12-15, disclosed to the SEC on 2023-12-19.
Scheduled sale ($2.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.98 | 11,018 | $716K | 27.5% |
| 2 | $64.98 | 11,018 | $716K | 27.5% |
| 3 | $65.01 | 8,300 | $540K | 20.7% |
| 4 | $65.38 | 3,982 | $260K | 10.0% |
| 5 | $65.38 | 3,982 | $260K | 10.0% |
| 6 | $65.41 | 1,700 |
| $111K |
| 4.3% |
| Total | $65.08 avg | 40,000 | $2.6M | 100% |
| Filing → |
| NARI | SELL | 2024-11-20 | $5.5M | — | Filing → |
| NARI | SELL | 2024-10-31 | $2.0M | — | Filing → |
| NARI | SELL | 2024-10-18 | $3.6M | — | Filing → |